It has recently been reported that FABP4 is detected in serum and cultured adipocyte supernatants [79] and that the serum concentration of FABP4 is associated with obesity, type 2 diabetes, and cardiovascular diseases [79–82]. Here, FABP4 is linked to obesity due to melanocortin 4 receptor deficiency.